Literature DB >> 21738007

Interaction of the ARF tumor suppressor with cytosolic HSP70 contributes to its autophagy function.

Julia Pimkina1, Maureen E Murphy.   

Abstract

The p14/p19 (ARF) (ARF) tumor suppressor gene is frequently mutated in human cancer. Recently ARF has been shown to localize to mitochondria and to induce autophagy. However the controls that regulate the trafficking of ARF to mitochondria remain unknown. We recently reported that 2-phenylethynesulfonamide (PES) selectively interacts with cytosolic heat shock protein 70 (HSP70) and inhibits its function; we further showed that PES promotes the death of tumor cells, and that this is associated with an impairment of lysosome function and an inhibition of autophagy. In the present work we used a mass spectrometry-based approach to identify mitochondrial ARF-binding proteins. We report that mitochondrial ARF interacts with HSP70. We show that treatment of cells with PES blocks the trafficking of ARF to mitochondria, indicating that interaction with HSP70 mediates the mitochondrial localization of ARF. We also show that PES inhibits the ability of ARF to induce autophagy, supporting the premise that localization to this organelle is critical for ARF-induced autophagy. Finally, we report that cells expressing high levels of ARF are more sensitive to PES than counterparts with ARF silenced. High levels of ARF are characteristic of tumor cells with enhanced MAPK signaling and advanced stage; therefore, these data support the premise that PES may show preferential cytotoxicity to advanced stage cancers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21738007      PMCID: PMC3218591          DOI: 10.4161/cbt.12.6.15976

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  18 in total

1.  The tetramerization domain of p53 is required for efficient BAK oligomerization.

Authors:  E Christine Pietsch; J I-Ju Leu; Amanda Frank; Patrick Dumont; Donna L George; Maureen E Murphy
Journal:  Cancer Biol Ther       Date:  2007-07-10       Impact factor: 4.742

2.  p53-independent functions of the p19(ARF) tumor suppressor.

Authors:  J D Weber; J R Jeffers; J E Rehg; D H Randle; G Lozano; M F Roussel; C J Sherr; G P Zambetti
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

3.  A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death.

Authors:  Sharon Reef; Einat Zalckvar; Ohad Shifman; Shani Bialik; Helena Sabanay; Moshe Oren; Adi Kimchi
Journal:  Mol Cell       Date:  2006-05-19       Impact factor: 17.970

4.  Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation.

Authors:  Evguenia Strom; Swati Sathe; Pavel G Komarov; Olga B Chernova; Ivanda Pavlovska; Inna Shyshynova; Dmitry A Bosykh; Lyudmila G Burdelya; Roger M Macklis; Rami Skaliter; Elena A Komarova; Andrei V Gudkov
Journal:  Nat Chem Biol       Date:  2006-07-23       Impact factor: 15.040

5.  ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

Authors:  Y Zhang; Y Xiong; W G Yarbrough
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

6.  The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

Authors:  J Pomerantz; N Schreiber-Agus; N J Liégeois; A Silverman; L Alland; L Chin; J Potes; K Chen; I Orlow; H W Lee; C Cordon-Cardo; R A DePinho
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

7.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

8.  The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53.

Authors:  K D Robertson; P A Jones
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

9.  Mitochondrial p32 is a critical mediator of ARF-induced apoptosis.

Authors:  Koji Itahana; Yanping Zhang
Journal:  Cancer Cell       Date:  2008-06       Impact factor: 31.743

10.  Stage-specific sensitivity to p53 restoration during lung cancer progression.

Authors:  David M Feldser; Kamena K Kostova; Monte M Winslow; Sarah E Taylor; Chris Cashman; Charles A Whittaker; Francisco J Sanchez-Rivera; Rebecca Resnick; Roderick Bronson; Michael T Hemann; Tyler Jacks
Journal:  Nature       Date:  2010-11-25       Impact factor: 49.962

View more
  7 in total

1.  ETV1 positively regulates transcription of tumor suppressor ARF.

Authors:  Evan Zynda; Mark W Jackson; Partho Bhattacharya; Eugene S Kandel
Journal:  Cancer Biol Ther       Date:  2013-10-23       Impact factor: 4.742

2.  Bax, Bcl2, and p53 differentially regulate neomycin- and gentamicin-induced hair cell death in the zebrafish lateral line.

Authors:  Allison B Coffin; Edwin W Rubel; David W Raible
Journal:  J Assoc Res Otolaryngol       Date:  2013-07-03

Review 3.  Broad targeting of resistance to apoptosis in cancer.

Authors:  Ramzi M Mohammad; Irfana Muqbil; Leroy Lowe; Clement Yedjou; Hsue-Yin Hsu; Liang-Tzung Lin; Markus David Siegelin; Carmela Fimognari; Nagi B Kumar; Q Ping Dou; Huanjie Yang; Abbas K Samadi; Gian Luigi Russo; Carmela Spagnuolo; Swapan K Ray; Mrinmay Chakrabarti; James D Morre; Helen M Coley; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; William G Helferich; Xujuan Yang; Chandra S Boosani; Gunjan Guha; Dipita Bhakta; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; W Nicol Keith; Alan Bilsland; Dorota Halicka; Somaira Nowsheen; Asfar S Azmi
Journal:  Semin Cancer Biol       Date:  2015-04-28       Impact factor: 15.707

4.  Inhibition of stress-inducible HSP70 impairs mitochondrial proteostasis and function.

Authors:  Julia I-Ju Leu; Thibaut Barnoud; Gao Zhang; Tian Tian; Zhi Wei; Meenhard Herlyn; Maureen E Murphy; Donna L George
Journal:  Oncotarget       Date:  2017-07-11

Review 5.  It's Getting Complicated-A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy.

Authors:  Che-Pei Kung; Jason D Weber
Journal:  Front Cell Dev Biol       Date:  2022-01-26

Review 6.  Direct and/or Indirect Roles for SUMO in Modulating Alpha-Synuclein Toxicity.

Authors:  Shamini Vijayakumaran; Mathew B Wong; Helma Antony; Dean L Pountney
Journal:  Biomolecules       Date:  2015-07-24

7.  Peptide-based tumor inhibitor encoding mitochondrial p14(ARF) is highly efficacious to diverse tumors.

Authors:  Ken Saito; Hidekazu Iioka; Chie Kojima; Mikako Ogawa; Eisaku Kondo
Journal:  Cancer Sci       Date:  2016-08-04       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.